Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000064

Senior Vice President, Finance sold 9,854 shares at an average $69.72 ($687,035)

  • Senior Vice President, Finance acquired 9,459 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Agarwal Arjun · Senior Vice President, Finance

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-12 Exercise or conversion : show line 1 in the form 10b5-1 +8,000 $12.50 $100,000 25,294 D
2026-06-12 Exercise or conversion : show line 2 in the form 10b5-1 +1,459 $34.39 $50,175 26,753 D
2026-06-12 Sale : show line 3 in the form 10b5-1 −1,859 $68.34 $127,048 24,894 D
2026-06-12 Sale : show line 4 in the form 10b5-1 −4,340 $69.85 $303,154 20,554 D
2026-06-12 Sale : show line 5 in the form 10b5-1 −3,260 $70.34 $229,306 17,294 D
2026-06-15 Sale : show line 6 in the form 10b5-1 −395 $69.69 $27,528 16,899 D
Open-market sales · 9,854 sh · avg $69.72 · $687,035

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-06-12 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) −8,000 110,000 D
2026-06-12 Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (right to buy) −1,459 62,708 D
Loading xslF345X06/form4.xml…